OFIRMEV (ACETAMINOPHEN)

CHEBI:CHEBI_750494

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
483017
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20241231
active_ingredient_name
ACETAMINOPHEN
unii
362O9ITL9D
dosage_form
INJECTION, SOLUTION
active_ingredient_strength
10 mg/mL
route
INTRAVENOUS
marketing_start_date
20191221
package_marketing_start_date
20191221
labeler_name
HF Acquisition Co LLC, DBA HealthFirst
manufacturer_name
HF Acquisition Co LLC, DBA HealthFirst
generic_name
OFIRMEV (ACETAMINOPHEN)
brand_name
OFIRMEV (ACETAMINOPHEN)
brand_name_base
OFIRMEV (ACETAMINOPHEN)
product_ndc
51662-1424
application_number
NDA022450
spl_id
9f34d89a-4c89-2e76-e053-2995a90aac7d
package_ndc
51662-1424-1
package_description
100 mL in 1 VIAL, GLASS (51662-1424-1)
spl_set_id
9a38f63a-8852-6dab-e053-2a95a90a90d6
upc
0343825102017
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class